Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

New generation must take South Africa into the Promised Land
2012-07-23

 

Prof. Somadoda Fikeni talks about Reconciliation and Social Justice on Nelson Mandela Day.
Photo: Johan Roux
18 July 2012

 

Former President Nelson Mandela was part of the Moses generation that took people out of bondage. What the country now needs is the Joshua generation that will take it into the promise land.

This is according to political analyst and public commentator, Prof. Somadoda Fikeni. He was speaking to staff and students participating in the Global Leadership Summit, which took place on the Bloemfontein Campus from 8-20 July 2012. Prof. Fikeni took part in a panel discussion on Justice and Reconciliation. He and other panellists observed that there were still many challenges facing reconciliation in South Africa.

Referring to controversial statements made by Helen Zille, Julius Malema and Pieter Mulder, Prof. Fikeni said public discourse had become toxic and that the country was faced by a leadership crisis.

Ms Yasmin Sooka, a former Commissioner of the Truth and Reconciliation Commission (TRC) and Executive Director of the Foundation for Human Rights South Africa, asked if reconciliation had not come at the expense of redress. She said that to date there had been no restitution.

Ms Lihlumelo Toyana, a post-graduate student at the university, was also part of the panel. She told the audience that 18 years into democracy, there are still people waiting for justice. Toyana said young people hoped to see change and wondered if South Africans would ever sit down and have dialogue about the past. “We need closure; we need to take the country forward.”

The other panelists were lawyer, politician and former Human Rights Commissioner Prof. Leon Wessels; a professor from the University of Cape Town’s Law Faculty, Prof. Jaco Barnard-Naude; and psychologist, Prof. Alain Tschudin.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept